EXPERIENCES

COVID-19 Experience

NO. YEAR PHASE STUDY TYPE INDICATION
1 2021 III Local COVID-19 치료제
2 2021 Consulting Local COVID-19 치료제
3 2021 II Local COVID-19 치료제
4 2021 Consulting Local COVID-19 치료제
5 2021 II Local COVID-19 치료제
6 2021 II/III Local COVID-19 치료제
7 2021 III Global COVID-19 Vaccine
8 2021 Consulting Global COVID-19 Vaccine
9 2021 I/IIa Local COVID-19 Vaccine
10 2021 II/III Global COVID-19 치료제
11 2021 II Local COVID-19 치료제
12 2021 I/II Local COVID-19 치료제
13 2021 II Local COVID-19 치료제
14 2021 III Local COVID-19 치료제
15 2021 I/IIa Local COVID-19 Vaccine
16 2021 II Local COVID-19 치료제
17 2020 I/II Local COVID-19 Vaccine
18 2020 I Local COVID-19 치료제
19 2020 III Global COVID-19 Vaccine
20 2020 II Local COVID-19 치료제
21 2020 II Global COVID-19 치료제
22 2020 II Local COVID-19 치료제
23 2020 II Local COVID-19 치료제
24 2020 II Local COVID-19 치료제
25 2020 I/IIa Local COVID-19 Vaccine
26 2020 I/IIa Local COVID-19 Vaccine
27 2020 Medical Device Local COVID-19 진단키트
28 2020 I/IIa Local COVID-19 치료제
[Update on 2021.12.31]
치료제 백신 진단키트 20181614121086420

* LSK Global PS 는 COVID-19 극복을 위해 치료제 개발 19건(Global 2, Local 17), 백신 개발 8건(Global 3, Local 5)과 진단키트 개발 1건의 임상시험을 수행하고 있습니다. (2021년 12월 31일 기준)